Published in Hepatitis Weekly, January 29th, 2001
Hepatitis C virus (HCV) not only impacts the liver, but has been associated with a chronic disease of the kidneys called cryoglobulinemic glomerulonephritis. In the past, this disease has been treated with immunosuppressive therapies, but that is no longer recommended for patients with viral infections.
The new research was performed in Italy, where 13 patients were randomly assigned to receive six months of treatment with prednisone, a steroid commonly used for treating...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.